Clinical Trial Update: Study of Plerixafor Combined With Cytarabine and Daunorubicin in Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

A Phase 1 study of combining Plerixafor with cytarabine and daunorubicin in adults with newly diagnosed acute myeloid leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Daunorubicin (daunorubicin)
• Plerixafor (Plerixafor)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Acute Myeloid Leukemia | Phase 1 | Status: COMPLETED